By: Marilyn McGoldrick, Esq. The Food and Drug Administration recently issued a Drug Safety Communication warning doctors and patients that taking the new class of diabetes drugs known as SGLT2 inhibitors — including Invokana — may lead to high levels of blood acids called ketones, a serious medical condition called ketoacidosis. Diabetic ketoacidosis can cause… Read More

by Marilyn T. McGoldrick, Esq. Takeda Pharmaceuticals executives have reportedly offered more than $2.3 billion dollars to resolve the more than 8,000 lawsuits alleging that it hid the bladder cancer risks of its popular diabetes drug Actos. The settlement must still be approved, but reportedly the details of the settlement are final. If you or a… Read More

Posted by Marilyn McGoldrick on April 8, 2015 12:22:16 PM This week several sources have reported that Takeda Pharmaceuticals, the Japanese manufacturer of the diabetes drug Actos, is close to settling all outstanding Actos lawsuits filed against it around the country in both state and federal courts. Bloomberg News reports that Takeda has offered $2.2… Read More

Posted by Marilyn McGoldrick on Oct 7, 2014 1:09:00 PM On Friday a state court jury awarded 79-year old Frances Wisniewski $2,050,000 in compensatory damages in her lawsuit against Takeda Pharmaceuticals for her development of bladder cancer after taking Actos to help control her diabetes. The jury rejected Takeda’s claim that Ms. Wisniewski’s smoking caused her bladder… Read More

Posted by Marilyn McGoldrick on Jun 3, 2013 3:53:00 PM Since their use became common in the 1990s, “statins” have been prescribed for millions of patients, earning drug companies hundreds of billions in revenue. Now, however, after almost three decades of heavy usage, new studies suggest that these hyper-prescribed drugs may be linked to increased… Read More